Ondine Biomedical (FRA:VF5) E10: €-0.16 (As of Dec. 2024)


FRA:VF5 Ondine Biomedical Inc FRA:VF5
47 GF Score
Price €0.15
View Full Analysis

What is Ondine Biomedical E10?

Ondine Biomedical FRA:VF5 47 E10 is €-0.16 as of Dec. 2024. GuruFocus rates FRA:VF5 with a GF Score™ of 47/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ondine Biomedical's adjusted earnings per share data for the fiscal year that ended in Dec. 2024 was €-0.047. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.16 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-28), Ondine Biomedical's current stock price is € 0.15. Ondine Biomedical's E10 for the fiscal year that ended in Dec. 2024 was €-0.16. Ondine Biomedical's Shiller PE Ratio of today is .


Ondine Biomedical  (FRA:VF5) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ondine Biomedical E10 Related Terms


Ondine Biomedical E10 Historical Data

* Premium members only.

The historical data trend for Ondine Biomedical's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ondine Biomedical E10 Chart

Ondine Biomedical Annual Data
Trend Dec09 Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.19 -0.16 -0.16

Ondine Biomedical Semi-Annual Data
Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 0.00 -0.16 0.00 -0.16

FRA:VF5 vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Ondine Biomedical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ondine Biomedical Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ondine Biomedical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ondine Biomedical's Shiller PE Ratio falls into.


FRA:VF5
47GF Score
Ondine Biomedical Inc FRA:VF5
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ondine Biomedical E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ondine Biomedical's adjusted earnings per share data for the fiscal year that ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.047/127.3637*127.3637
=-0.047

Current CPI (Dec. 2024) = 127.3637.

Ondine Biomedical Annual Data

per_share_eps CPI Adj_EPS
200912 -0.540 90.703 -0.758
201012 -0.300 92.836 -0.412
201712 -0.022 103.345 -0.027
201812 -0.056 105.399 -0.068
201912 -0.049 107.769 -0.058
202012 -0.054 108.559 -0.063
202112 -0.436 113.774 -0.488
202212 -0.069 120.964 -0.073
202312 -0.048 125.072 -0.049
202412 -0.047 127.364 -0.047

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.16 mean?
Ondine Biomedical (FRA:VF5) has a E10 of €-0.16 as of Dec. 2024. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ondine Biomedical and its competitors.
Is Ondine Biomedical's E10 too high?
Ondine Biomedical's current E10 is €-0.16. Overall, Ondine Biomedical has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Ondine Biomedical's E10 compare to VRTX and REGN?
Ondine Biomedical's E10 of €-0.16 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ondine Biomedical and its competitors. Ondine Biomedical's current E10 is €-0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ondine Biomedical stock overvalued right now?
Ondine Biomedical (FRA:VF5) has a current E10 of €-0.16. The current E10 is €-0.16. Ondine Biomedical's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Ondine Biomedical (FRA:VF5), the current E10 is €-0.16 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ondine Biomedical Business Description

Address 1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
47GF Score

Get the complete analysis for FRA:VF5

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.15
Price